3M17
Crystal structure of human FcRn with a monomeric peptide inhibitor
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | ALS BEAMLINE 4.2.2 |
| Synchrotron site | ALS |
| Beamline | 4.2.2 |
| Collection date | 2007-09-01 |
| Wavelength(s) | 1.0 |
| Spacegroup name | C 2 2 21 |
| Unit cell lengths | 114.320, 118.300, 248.330 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 41.100 - 2.600 |
| R-factor | 0.26408 |
| Rwork | 0.261 |
| R-free | 0.32548 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 1exu |
| RMSD bond length | 0.006 |
| RMSD bond angle | 0.962 |
| Data reduction software | d*TREK |
| Data scaling software | d*TREK |
| Phasing software | PHASER |
| Refinement software | REFMAC (5.2.0019) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 41.100 | 2.690 |
| High resolution limit [Å] | 2.600 | 2.600 |
| Number of reflections | 51434 | |
| Completeness [%] | 98.7 | 97.8 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 |






